NeuroSentry's clinical co-founder, Mauro Caffarelli, MD, received a 2025–2026 Weill Institute–Catalyst Award for the project, “An Improved System for Periprocedural Stroke Detection and Treatment.”
Periprocedural stroke presents a particularly difficult clinical challenge because patients under anesthesia or deep sedation cannot participate in a conventional neurological examination. As a result, neurological injury may remain unrecognized during a critical window for treatment.
The project is advancing NeuroSentry's neurophysiologic monitoring technology to provide clinicians with an additional tool for recognizing potential stroke during procedures, with the goal of enabling earlier diagnosis and treatment.
More Details: https://weill.ucsf.edu/content/an-improved-system-for-periprocedural-stroke-detection-and-treatment
